LV10288B - Peptide compounds - Google Patents

Peptide compounds

Info

Publication number
LV10288B
LV10288B LVP-93-459A LV930459A LV10288B LV 10288 B LV10288 B LV 10288B LV 930459 A LV930459 A LV 930459A LV 10288 B LV10288 B LV 10288B
Authority
LV
Latvia
Prior art keywords
pct
alpha
sec
date
peptide
Prior art date
Application number
LVP-93-459A
Other languages
English (en)
Other versions
LV10288A (lv
Inventor
Kjell Undheim
Peter Kremminger
Magne Solbakken
Erik Agner
Meinolf Lange
Original Assignee
Hafslund Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929211676A external-priority patent/GB9211676D0/en
Priority claimed from GB929211675A external-priority patent/GB9211675D0/en
Priority claimed from GB929211674A external-priority patent/GB9211674D0/en
Application filed by Hafslund Nycomed As filed Critical Hafslund Nycomed As
Publication of LV10288A publication Critical patent/LV10288A/xx
Publication of LV10288B publication Critical patent/LV10288B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4722—G-proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/067—Hemoregulatory peptides based on sequence Glp-Glu-Asp-Cys-Lys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LVP-93-459A 1992-06-02 1993-06-02 Peptide compounds LV10288B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929211676A GB9211676D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211675A GB9211675D0 (en) 1992-06-02 1992-06-02 Peptide compounds
GB929211674A GB9211674D0 (en) 1992-06-02 1992-06-02 Peptide compounds

Publications (2)

Publication Number Publication Date
LV10288A LV10288A (lv) 1994-10-20
LV10288B true LV10288B (en) 1995-04-20

Family

ID=27266223

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-459A LV10288B (en) 1992-06-02 1993-06-02 Peptide compounds

Country Status (11)

Country Link
US (1) US5610141A (zh)
EP (1) EP0673388B1 (zh)
JP (1) JPH08501066A (zh)
CN (1) CN1086221A (zh)
AT (1) ATE172204T1 (zh)
AU (1) AU4340393A (zh)
DE (1) DE69321605D1 (zh)
EE (1) EE9400180A (zh)
LV (1) LV10288B (zh)
NO (1) NO944669D0 (zh)
WO (1) WO1993024523A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL104323A0 (en) * 1992-01-10 1993-05-13 Smithkline Beecham Corp Hemoregulatory peptides
GB9324691D0 (en) * 1993-12-01 1994-01-19 Hafslund Nycomed As Peptide compounds
WO2012121057A1 (ja) 2011-03-09 2012-09-13 Jitsubo株式会社 新規な非ペプチド性架橋構造を含む架橋ペプチド、ならびに該架橋ペプチドの合成方法および該方法に用いる新規な有機化合物
US9365615B2 (en) 2013-09-09 2016-06-14 Jitsubo Co., Ltd. Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
CN108059663A (zh) * 2018-02-10 2018-05-22 润辉生物技术（威海）有限公司 一种来考诺肽的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058512A (en) * 1975-04-28 1977-11-15 Ab Kabi Synthetic peptides having growth promoting activity
GB8626539D0 (en) * 1986-11-06 1986-12-10 Nycomed As Peptide compounds
ZW11290A1 (en) * 1989-07-14 1990-10-31 Smithkline Beecham Corp Hemoregulatory peptides

Also Published As

Publication number Publication date
LV10288A (lv) 1994-10-20
CN1086221A (zh) 1994-05-04
ATE172204T1 (de) 1998-10-15
DE69321605D1 (de) 1998-11-19
AU4340393A (en) 1993-12-30
EP0673388B1 (en) 1998-10-14
NO944669L (no) 1994-12-02
EP0673388A1 (en) 1995-09-27
WO1993024523A1 (en) 1993-12-09
JPH08501066A (ja) 1996-02-06
NO944669D0 (no) 1994-12-02
EE9400180A (et) 1996-02-15
US5610141A (en) 1997-03-11

Similar Documents

Publication Publication Date Title
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
SG75092A1 (en) Therapeutic peptide derivatives
HK1013283A1 (en) Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
TR199901949T2 (xx) Lemfositik t�m�rler i�in �areler.
KR0180256B1 (en) Bpc peptides, their preparation and use
LV10288B (en) Peptide compounds
ZA896980B (en) Peptide compounds
NO944668L (no) Dobbeltkjedete peptidforbindelser med hemoregulatorisk aktivitet
ATE174927T1 (de) Haemoregulatorische penta-oder hexapeptide
GB9604518D0 (en) Novel compounds
ATE97912T1 (de) Renin-hemmende di- und tripeptide, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung.